Abstract
Structure-based drug design focuses on the search, design, and optimization of a small molecule that fits well into the binding pocket of a target protein to form energetically favorable interactions. Initially, a detailed analysis of the protein is performed. All information about its structure and that of related proteins are evaluated. Next, the properties of the binding pocket are thoroughly explored, and areas are sought where an optimal binding is to be expected. Experimental techniques as well as computer methods are employed to discover a lead structure from a screening library (Chap. 7, “Screening Technologies for Lead Structure Discovery”). Alternatively, approaches are also applied that begin with a small molecular “seed” in the binding pocket, which is then allowed to “grow” to a potent ligand by using a stepwise iterative design. This approach uses fast docking techniques that propose relevant binding geometries. The geometries are evaluated with a scoring function, which estimates whether they are energetically favorable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
General Literature
Beddell CR (ed) (1992) The design of drugs to macromolecular targets. Wiley, Chichester
Böhm HJ, Schneider G (2006) Molecular recognition in protein–ligand interactions. In: Mannhold R, Kubinyi H, Folkers G (eds) Methods and principles in medicinal chemistry, vol 19. Wiley-VCH, Weinheim
Böhm HJ (1993) Ligand design. In: Kubinyi H (ed) 3D QSAR in drug design. Leiden, Escom, pp 386–405
Borman S (1992) New 3-D search and de novo design techniques aid drug development. Chem Eng News 10:18–26
Branden C, Tooze J (1999) Introduction to protein structure, 2nd edn. Garland, New York
Goodford P (1984) Drug design by the method of receptor fit. J Med Chem 27:557–564
Greer J, Erickson JW, Baldwin JJ, Varney MD (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem 37:1035–1054
Hubbard TJP, Lesk AM (1995) Modelling protein structures. In: Goodfellow JM (ed) Computer modelling in molecular biology. Weinheim, VCH
Hutchins C, Greer J (1991) Comparative modeling of proteins in the design of novel renin inhibitors. Crit Rev Biochem Molec Biol 26:77–127
Kuntz ID, Meng EC, Shoichet BK (1994) Structure-based molecular design. Acc Chem Res 27:117–123
Kuntz ID (1992) Structure-based strategies for drug design and discovery. Science 257:1078–1082
Martin YC (1992) 3D database searching in drug design. J Med Chem 35:2145–2154
Müller K (1995) De novo design. In: Anderson PS, Kenyon GL, Marshall GR (eds) Persp drug discovery and de-sign, vol 3. Escom, Leiden
Schneider G, Baringhaus KH (2008) Molecular design. Wiley-VCH, Weinheim
Special Literature
Böhm HJ (1992a) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comp-Aided Molec Des 6:593–606
Böhm HJ (1992b) The computer program Ludi: a new method for the de novo design of enzyme inhibitors. J Comp-Aided Molec Des 6:61–78
Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH (1990) Model of the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 213:899–929
Hibert M, Trumpp-Kallmeyer S, Hoflack J, Bruinvels A (1993) This is not a G-protein-coupled receptor. Trends Pharm Sci 14:7–12
Hoflack J, Trumpp-Kallmeyer S, Hibert M (1994) Re-evaluation of bacteriorhodopsin as a model for G-protein-coupled receptors. Trends Pharm Sci 15:7–9
Overington J, Johnson MS, Sali A, Blundell TL (1990) Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction. Proc Roy Soc Lond B 241:132–145
Ring CS et al (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci 90:3583–3587
Sali A, Blundell TL (1990) Definition of general topological equivalence in protein structures. J Mol Biol 212:403–428
Schertler GFX, Villa C, Henderson R (1993) Projection structure of Rhodopsin. Nature 362:770–772
Travis J (1993) Proteins and organic solvents make an eye-opening mix. Science 262:1374
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Klebe, G. (2013). Protein Modeling and Structure-Based Drug Design. In: Klebe, G. (eds) Drug Design. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-17907-5_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17906-8
Online ISBN: 978-3-642-17907-5
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences